Alligator Bioscience AB announced that the composition of the Nomination Committee prior to the Annual General Meeting on May 5, 2022 has changed as a result of a change of ownership. The composition of the Nomination Committee prior to the 2022 Annual General Meeting was announced in a press release on November 3, 2021. Allegro Investment Inc. has since December 2021 acquired shares corresponding to approximately 22.2% of the total number of shares and votes in the company and thereby become the large shareholder in Alligator Bioscience.

AB. As a result of the change of ownership, the composition of the Nomination Committee, in accordance with the instructions for the Nomination Committee adopted by the Annual General Meeting, has changed by Claus Asbjørn Andersson (representing Sunstone Life Science Ventures II K /S) leaving the Nomination Committee and Jan Lundström (representing Allegro Investment Inc.) entered as a new member of the Nomination Committee.